MEDPAL AI is trading at £6.05, up +5.30% as it stages a technical rebound after the placing-related selloff.

  • The announced £5 million placing involves 100 million new shares issued at 5.0 pence, raising dilution concerns.
  • September annualised revenue reportedly reached £35 million, up from £28 million in August.
  • No new September 22 catalyst was identified; evidence supports a rebound rather than a confirmed fresh company-specific trigger.